Ridaura® film-coated tablets contain auranofin 3 mg. It is used together with other treatments, such as non-steroidal anti-inflammatory drugs (NSAIDs), for active rheumatoid arthritis. It may prevent or reduce further damage to the joints, and can also reduce the inflammation in the joints.

Ridaura® is a fully funded Prescription medicine (under s29).

For key risk information about Ridaura® such as warnings, side effects and interactions, please refer to the Consumer Medicine Information and Data Sheet below.

All medicines have benefits and risks. Use only as directed and if symptoms persist see your doctor, pharmacist or healthcare professional.


Consumer Medicine Information

Data Sheet (for healthcare professionals)